Current Studies
Study Information
Location
Status
Age Range
Sex
Max Compensation
ADHD (child)
A placebo controlled study evaluating the efficacy and safety of an investigational medication for Children with ADHD
Evansville
Owensboro
Owensboro
Enrolling
4-5 yrs
Male/Female
Up to $1900
ASCVD and Elevated LDL
A phase III study of an investigational medicine on major adverse CV events in patients with a history of ASCVD (atherosclerotic cardiovascular disease) events or at a high risk for a first event
Bowling Green
Evansville
Owensboro
Evansville
Owensboro
Enrolling
18+ yrs
Male/Female
Up to $1200
COPD
A phase III study to evaluate the efficacy and safety of an investigational medicine in adult participants with moderate to very severe chronic obstructive pulmonary disease.
Bowling Green
Owensboro
Owensboro
Enrolling
40-80 yrs
Male/Female
Up to $2600
COPD and Chronic Bronchitis
A 52-week study to evaluate the efficacy and safety of two doses of an investigational medicine in subjects with Chronic Obstructive Pulmonary Disease (COPD) and chronic bronchitis.
Bowling Green
Enrolling
40+ yrs
Male/Female
Up to $1450
Dyslipidemia and CV Risk
A phase III study to assess the effect of an investigational medicine on LDL-C patients with clinical ASCVD (atherosclerotic cardiovascular disease) or at risk for a first ASCVD event
Owensboro
Evansville
Evansville
Enrolling
18+ yrs
Male/Female
Up to $1350
LIPOPROTEIN (a)
A study to investigate the effect of an investigational medicine on the reduction of major adverse cardiovascular events in Adults with Elevated Lipoprotein(a)
Bowling Green
Enrolling
18+ yrs
Male/Female
Up to $2150
MIGRAINES IN CHILDREN
A double blind, placebo controlled study of an investigational medicine for Pediatric Migraines
Bowling Green
Evansville
Owensboro
Evansville
Owensboro
Enrolling
6-17 yrs
Male/Female
$200/$350
ATOPIC DERMATITIS (Eczema)
A phase 2 study of the effects of an investigational medicine in adults with moderate to severe atopic dermatitis
Owensboro
Coming Soon
18-75 yrs
Male/Female
Up to $1700
HEART FAILURE
A phase III study to evaluate the efficacy and safety of investigational medicines compared with placebo in participants with type 2 diabetes, hypertension and established cardiovascular disease
Bowling Green
Coming Soon
18+ yrs
Male/Female
Up to $3250